About Contact Us Careers

Propofol Market Size & Share, by Application (Procedural Sedation, General Anesthesia); Distribution Channel (Ambulatory Surgery Centers, Ophthalmic Clinics, Hospitals, Dental Clinics, Specialty Clinics); End-user (Seditionist, Anesthesiologists) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

  • Report ID: 3132
  • Published Date: Dec 26, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Propofol Market size was over USD 1.04 billion in 2024 and is projected to reach USD 2.01 billion by 2037, witnessing around 5.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of propofol is assessed at USD 1.09 billion.

As the number of medical procedures performed such as general surgical, orthodontic and dental surgical procedures, and cataract removal surgeries is increasing, the demand for propofol drug across the world is also projected to rise in the upcoming years. On an average, approximately 235 million surgeries are performed worldwide. According to the World Health organization (WHO), 58.9% of these surgeries occur in high-income countries. Along with this, growing requirement for minimally invasive surgery procedures globally is also expected to drive market growth in the coming years. Furthermore, research and development activities initiated by the top market players for commercialization as well as new product development is anticipated to offer ample growth opportunities to the market in the near future.

Propofol-Market
Discover Market Trends & Growth Opportunities: Request Free Sample PDF

Growth Drivers

  • High Influence of Propofol on the Anesthesia Practice

  • Rise in the Number of Surgical Procedures

Challenges

  • Major Side Effects Associated with Propofol Drug

Propofol Market: Key Insights

Report Attribute Details

Base Year

2024

Forecast Year

2025-2037

CAGR

5.2%

Base Year Market Size (2024)

USD 1.04 billion

Forecast Year Market Size (2037)

USD 2.01 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Access Detailed Forecasts & Data-Driven Insights: Request Free Sample PDF

Propofol Segmentation

The propofol market is segmented by application into procedural sedation and general anesthesia, out of which, the general anesthesia segment is estimated to hold a significant market share on the back of rising number of surgical procedures across the globe coupled with the easy availability of the drug. As per the U.S. National Institutes of Health, every day about 60,000 people in the nation undergo surgery under general anesthesia. Apart from this, the ability of anesthesia to enable painless medical procedures that lead to healthier and longer lives is also evaluated to boost growth of this market segment in the future. Additionally, on the basis of distribution channel, the segment for hospitals is expected to garner the largest market share over the forecast period, which can be ascribed to the high number of admissions and abundant availability of appropriate medical equipment in a hospital facility. 

Our in-depth analysis of the global propofol market includes the following segments:

 

By Application
  • Procedural Sedation
  • General Anesthesia

      

By Distribution Channel
  • Ambulatory Surgery Centers
  • Ophthalmic Clinics
  • Hospitals
  • Dental Clinics
  • Specialty Clinics

By End-user

 
  • Seditionist
  • Anesthesiologist
  • Others
Vishnu Nair
Vishnu Nair
Head - Global Business Development

Customize this report to your requirements — connect with our consultant for personalized insights and options.

Propofol Industry - Regional Synopsis

North America Market Statistics

On the basis of regional analysis, the global propofol market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa.  North America industry is expected to dominate majority revenue share by 2037, on the back of increase in the number of well-established healthcare facilities, high adoption of minimally invasive surgical procedures and easy availability of drugs in the region.

Europe Market Analysis

Furthermore, Europe is assessed to hold the second largest market share owing to the rising geriatric population in the region who need to be frequently operated with dental as well as ophthalmic surgical procedures. Additionally, increasing investments for drug development by market players in the region is also likely to fuel the propofol market growth in the region. 

Get Strategic Analysis by Region Now: Request Free Sample PDF

Companies Dominating the Propofol Landscape

    • Pfizer Inc. 
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • Bachem Holding AG
    • Porton Fine Chemicals Ltd.
    • SI Group, Inc.
    • AstraZeneca plc
    • Fresenius Kabi AG
    • Baxter Healthcare Corporation
    • Teva Pharmaceutical Industries Ltd.
    • Hikma Pharmaceuticals PLC
    • Mylan N.V.

Recent Developments

May 12th, 2020: Hikma Pharmaceuticals PLC, the multinational pharmaceutical company announced the launch of propofol injectable emulsion, USP, 20ml, 50ml as well as 100 ml vials, in the United States of America through its US affiliate, Hikma Pharmaceuticals USA Inc., by the approval of its supplemental Abbreviated New Drug Application by the U.S. Food and Drug Administration (FDA).

  • Report ID: 3132
  • Published Date: Dec 26, 2024
  • Report Format: PDF, PPT
  • Get detailed insights on specific segments/region
  • Inquire about report customization for your industry
  • Learn about our special pricing for startups
  • Request a demo of the report’s key findings
  • Understand the report’s forecasting methodology
  • Inquire about post-purchase support and updates
  • Ask About Company-Level Intelligence Additions

Have specific data needs or budget constraints?

customer-service Inquiry Before Buying

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of propofol is assessed at USD 1.09 billion.

Propofol Market size was over USD 1.04 billion in 2024 and is projected to reach USD 2.01 billion by 2037, witnessing around 5.2% CAGR during the forecast period i.e., between 2025-2037.

North America industry is expected to dominate majority revenue share by 2037, on the back of increase in the number of well-established healthcare facilities, high adoption of minimally invasive surgical procedures and easy availability of drugs in the region.

The major players in the market are Pfizer Inc., Bachem Holding AG, Porton Fine Chemicals Ltd., SI Group, Inc., AstraZeneca plc, and others.

Propofol Market Report Scope

GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

Connect with our Expert

Radhika Pawar
Radhika Pawar
Senior Research Analyst
Get a Free Sample

See how top U.S. companies are managing market uncertainty — get your free sample with trends, challenges, macroeconomic factors, charts, forecasts, and more.

Inquiry Before Buying Request Free Sample PDF

Copyright @ 2025 Research Nester. All Rights Reserved.

footer-bottom-logos